Thrombotic complications of vaccination against SARS-CoV-2: what pharmacovigilance reports tell us - and what they don't
- PMID: 33888525
- PMCID: PMC8061197
- DOI: 10.1183/13993003.01111-2021
Thrombotic complications of vaccination against SARS-CoV-2: what pharmacovigilance reports tell us - and what they don't
Abstract
Thrombotic complications of COVID-19 vaccination are very rare, but awareness is needed https://bit.ly/3n4vaXe
Conflict of interest statement
Conflict of interest: S.V. Konstantinides has received fees for consultancy and lecture honoraria from Bayer HealthCare, Boehringer Ingelheim, Actelion, Servier and BMS Pfizer; reimbursement for travel, accommodation and meeting expenses from Bayer HealthCare; and institutional grants from Boehringer Ingelheim, Bayer HealthCare, Daiichi Sankyo and Actelion.
Comment on
-
Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase.Eur Respir J. 2021 Jul 1;58(1):2100956. doi: 10.1183/13993003.00956-2021. Print 2021 Jul. Eur Respir J. 2021. PMID: 33863748 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous